Intervention Review

Piracetam for reducing the incidence of painful sickle cell disease crises

  1. Amani Al Hajeri1,*,
  2. Zbys Fedorowicz2,
  3. Ahmed Omran3,
  4. Ghazi O Tadmouri4

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 18 APR 2007

Assessed as up-to-date: 8 MAR 2011

DOI: 10.1002/14651858.CD006111.pub2

How to Cite

Al Hajeri A, Fedorowicz Z, Omran A, Tadmouri GO. Piracetam for reducing the incidence of painful sickle cell disease crises. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD006111. DOI: 10.1002/14651858.CD006111.pub2.

Author Information

  1. 1

    Ministry of Health, Department of Genetics, Awali, Bahrain

  2. 2

    Ministry of Health, Bahrain, UKCC (Bahrain Branch), Awali, Bahrain

  3. 3

    Ministry of Health, Medical Consultant, Medical Review Office, Manama, Bahrain

  4. 4

    Centre for Arab Genomic Studies, Dubai, United Arab Emirates

*Amani Al Hajeri, Department of Genetics, Ministry of Health, Box 25438, Awali, Bahrain.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 18 APR 2007


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.